AR and prostate carcinoma: The current study has discovered that USP14, one of the 19S proteasome-associated DUBs, is involved in the stabilization of AR proteins and promotes G0/G1 to S phase transition in human prostate cancer cells and also identified USP14 as a potential target for prostate cancer therapy.